Monika Peeters
- Infectious Diseases top 0.5%
- Epidemiology top 1%
- Hepatology top 0.2%
- Virology top 0.5%
- Molecular Biology
- Co-authors
- Brian WoodfallGoedele De SmedtOliver LenzRekha SinhaJane ScottMaria Beumont‐MauvielJohan VingerhoetsSivi Ouwerkerk‐Mahadevan
- Topics
- HIV/AIDS drug development and treatment (44 papers)Hepatitis C virus research (28 papers)HIV Research and Treatment (27 papers)
- Journals
- The LancetGastroenterologyHepatology
- Partner nations
- BelgiumUnited StatesUnited Kingdom
In The Last Decade
Monika Peeters
64 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Infectious Diseases 2.5k
- Epidemiology 2.3k
- Hepatology 2.3k
- Virology 1.5k
- Molecular Biology 253
Countries citing papers authored by Monika Peeters
This map shows the geographic impact of Monika Peeters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monika Peeters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monika Peeters more than expected).
Fields of papers citing papers by Monika Peeters
This network shows the impact of papers produced by Monika Peeters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monika Peeters. The network helps show where Monika Peeters may publish in the future.
Co-authorship network of co-authors of Monika Peeters
This figure shows the co-authorship network connecting the top 25 collaborators of Monika Peeters. A scholar is included among the top collaborators of Monika Peeters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monika Peeters. Monika Peeters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized study | 5 |
| 2 | 63 | |
| 3 | Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trialbreakdown → | 333 |
| 4 | 16 | |
| 5 | 69 | |
| 6 | 86 | |
| 7 | TMC435 IN COMBINATION WITH PEGINTERFERON ALPHA-2A/RIBAVIRIN IN TREATMENT-NAiVE PATIENTS INFECTED WITH HCV GENOTYPE 1: VIROLOGY ANALYSIS OF THE PILLAR STUDY | 8 |
| 8 | 1 | |
| 9 | 2 | |
| 10 | 9 | |
| 11 | 14 | |
| 12 | 23 | |
| 13 | Pharmacokinetics (PK) and Pharmacodynamics (PD) of Etravirine (ETR) in Treatment-Experienced HIV-1 Infected Patients: Pooled 48-Week Results of DUET-1 and DUET-2 | 5 |
| 14 | 33 | |
| 15 | 50 | |
| 16 | 103 | |
| 17 | 35 | |
| 18 | 34 | |
| 19 | 97 | |
| 20 | 33 |
About Monika Peeters
Monika Peeters is a scholar working on Virology, Hepatology and Infectious Diseases, having authored 64 papers that have together received 4.2k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (44 papers), Hepatitis C virus research (28 papers) and HIV Research and Treatment (27 papers). The work is most often cited by research in Virology (1.5k citations), Hepatology (2.3k citations) and Infectious Diseases (2.5k citations). Monika Peeters has collaborated with scholars based in Belgium, United States and United Kingdom. Frequent co-authors include Brian Woodfall, Goedele De Smedt, Oliver Lenz, Rekha Sinha, Jane Scott, Maria Beumont‐Mauviel, Johan Vingerhoets, Sivi Ouwerkerk‐Mahadevan, Ronald Kalmeijer and Guy De La Rosa. Their work appears in journals such as The Lancet, Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.